Showing results (1121-1130 of 2,407) with videos related to
Sort By:
Pageof 241
Future Medicinal Chemistry|February 28, 2026
Novel isocoumarin-pyrazole hybrids: synthesis, characterization, and investigation of their carbonic anhydrase inhibitory activitiesMehmet Onyilmaz, Mustafa Degirmenci, Simone Giovannuzzi, et al.Future Medicinal Chemistry|April 22, 2026
Design, synthesis and biological evaluation of a 4,6-di(aziridin-1-yl)-1,3,5-triazine-benzimidazole hybrid as a potential dual-targeting anticancer agentIvan S Chernov, Alexandra V Protas, Elena А Popova, et al.Future Medicinal Chemistry|May 27, 2026
Therapeutic potential of spirocyclopropyl oxindoles: latest developments in drug discoverySowmya Dastari, Nagula ShankaraiahFuture Medicinal Chemistry|June 8, 2026
Design and synthesis of pyrazole-heteroaryl arylhydrazone schiff base hybrids with antimicrobial and docking evaluationAsmaa L Alanzy, Mohamed N El-Bayaa, Dania Alweet, et al.Future Medicinal Chemistry|June 14, 2026
Butenolide-based human carbonic anhydrase (hCA) I/II inhibitors: integrated computational and biological evaluationSongul Bayrak, Cansu Ozturk, Serpil Gerni, et al.Future Medicinal Chemistry|June 16, 2026
Indole-based kinase modulators for NSCLC: recent advances in synthetic route, SAR and molecular docking studiesShivam Nag, Divyanshi Thakur, Kalicharan SharmaFuture Medicinal Chemistry|June 16, 2026
Thiazolidin-based dual Aurora kinase inhibitors with potent anticancer activityWalid E Elgammal, Hazem Elkady, Aisha A Alsfouk, et al.Future Medicinal Chemistry|June 15, 2026
Urease inhibitors: current advances, therapeutic potentials, and clinical challengesOmer Habis Alzoubi, Almu'atasim Khamees, Mohammad Basil Alzu'bi, et al.Future Medicinal Chemistry|July 3, 2023
Computational insights into novel inhibitor indole-heterocycle specific against glycogen phosphorylase isoenzymes interaction mechanismYoude Wang, Shuai Li, Zhiwei Yan, et al.Future Medicinal Chemistry|June 12, 2023
Structure-guided discovery of adenosine triphosphate-competitive casein kinase 2 inhibitorsShivani Patel, Vivek K Vyas, Manmohan Sharma, et al.Pageof 241